The forecasted rise in cases comes after NSW recorded 16,288 new cases today. 9News
could double within weeks as a sub-variant of the Omicron strain sweeps across the state, according to new data.
The forecasted rise in cases comes after NSW recorded 16,288 new cases today, marking a significant increase from the 8782 daily cases recorded on Sunday. NSW Health Minister Brad Hazzard told a NSW budget estimates hearing that preliminary data from the University of NSW has indicated COVID-19 cases could "more than double" within six weeks.He said the BA.2 sub-variant of Omicron, which is believed to be more infectious than the BA.1 lineage, was becoming the dominant Omicron variant in the community."But we are concerned at this point that BA.2 is amongst us and overtaking BA.1.
"While the community has gone to sleep on the virus, the virus hasn't gone to sleep on the community.Today just four COVID-19 related deaths were recorded in the state, compared to nine yesterday, and hospitalisations are also down. There are 991 COVID-19 patients in hospital - down from more than 1000 at the start of the week, and 39 in intensive care.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NSW Covid cases could double within six weeks due to Omicron BA.2 subvariantHealth minister Brad Hazzard says modelling shows the state will see a sharp rise in coming weeks and urges more people to get their booster shot
Read more »
‘Concerning’: NSW COVID-19 cases tipped to double within weeksModelling suggests daily COVID-19 cases in NSW could hit 20,000 to 30,000 in early April, with a more transmissible version of the Omicron variant becoming dominant.
Read more »
NSW and Victoria see jump in daily COVID-19 casesNew South Wales and Victoria have both recorded a jump in daily COVID19 cases as the nation's three-dose vaccination rate continues to inch higher. 9News
Read more »
Sydney COVID-19 patients developed ‘resistance’ to common treatmentSotrovimab, a treatment administered via intravenous drip to patients considered to be at risk of severe disease from the virus, has been widely used at hospitals.
Read more »
Sydney COVID-19 patients developed ‘resistance’ to common treatmentA drug widely used to treat COVID-19 patients at risk of serious illness appears to be ineffective in some instances, new research shows. Sotrovimab COVID19 COVID19Vic COVID19NSW
Read more »